Glucocorticoids are used across our institution for chronic obstructive pulmonary disease (COPD), autoimmune disease, cancer, and transplant care. Adrenal insufficiency is both common and preventable, but patients often experience symptoms that go unnoticed or are misattributed to other illnesses. As a result, avoidable morbidity continues to occur at the patient and community level. Healthcare systems also struggle with inconsistent tapering practices, limited monitoring, and poor communication across transitions of care. 
 
Without standardized protocols, physician performance varies widely, leading to gaps in safety, documentation, and follow up. Glucocorticoid withdrawal spans multiple specialties, lacks universal tapering standards, and depends heavily on clinician judgment rather than system level safeguards. These inconsistencies directly affect healthcare quality by increasing emergency visits, readmissions, and preventable complications, as such it is imperative to build consensus through a unified, evidence-based tapering protocol embedded across specialties, improving physician performance and reducing variation in care.